Lineage Cell Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Lineage Cell Therapeutics, Inc. (LCTX) reported Basic Shares Outstanding (Weighted Average) of 249.50 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 249.50M shares, a 9.26% increase year-over-year.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 245.03M shares, a 8.39% increase year-over-year.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 237.17M shares, a 1.26% decline year-over-year.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 228.85M shares, a 21.19% increase year-over-year.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 230.12M shares, a 14.95% increase from fiscal 2024.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 200.19M shares, a 15.94% increase from fiscal 2023.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 172.66M shares, a 1.69% increase from fiscal 2022.
- Lineage Cell Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 169.79M shares, a 3.22% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 249.50M shares 10-Q · filed 2026-08-06 | 247.28M shares 10-Q · filed 2026-08-06 | 243.90M shares derived: average of 3 quarters · filed 2026-08-06 | 240.14M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 245.03M shares 10-Q · filed 2026-05-12 | 241.10M shares derived: average of 2 quarters · filed 2026-05-12 | 237.02M shares derived: average of 3 quarters · filed 2026-05-12 | 234.85M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | 237.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 233.01M shares derived: average of 2 quarters · filed 2026-03-05 | 231.46M shares derived: average of 3 quarters · filed 2026-08-06 | 230.12M shares 10-K · filed 2026-03-05 | |||
| 2025-09-30 | 228.85M shares 10-Q · filed 2025-11-06 | 228.60M shares derived: average of 2 quarters · filed 2026-08-06 | 227.76M shares 10-Q · filed 2025-11-06 | 230.86M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | 228.36M shares 10-Q · filed 2026-08-06 | 227.21M shares 10-Q · filed 2026-08-06 | 231.53M shares derived: average of 3 quarters · filed 2026-08-06 | 220.86M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | 226.05M shares 10-Q · filed 2026-05-12 | 233.12M shares derived: average of 2 quarters · filed 2026-05-12 | 218.36M shares derived: average of 3 quarters · filed 2026-05-12 | 210.97M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 240.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 214.51M shares derived: average of 2 quarters · filed 2026-03-05 | 205.95M shares derived: average of 3 quarters · filed 2026-03-05 | 200.19M shares 10-K · filed 2026-03-05 | |||
| 2024-09-30 | 188.84M shares 10-Q · filed 2025-11-06 | 188.82M shares derived: average of 2 quarters · filed 2025-11-06 | 186.86M shares 10-Q · filed 2025-11-06 | 183.89M shares derived: average of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | 188.81M shares 10-Q · filed 2025-08-12 | 185.86M shares 10-Q · filed 2025-08-12 | 182.24M shares derived: average of 3 quarters · filed 2025-08-12 | 180.40M shares derived: average of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | 182.91M shares 10-Q · filed 2025-05-13 | 178.96M shares derived: average of 2 quarters · filed 2025-05-13 | 177.60M shares derived: average of 3 quarters · filed 2025-05-13 | 175.85M shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 175.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 174.94M shares derived: average of 2 quarters · filed 2025-03-10 | 173.49M shares derived: average of 3 quarters · filed 2025-03-10 | 172.66M shares 10-K · filed 2025-03-10 | |||
| 2023-09-30 | 174.87M shares 10-Q · filed 2024-11-14 | 172.73M shares derived: average of 2 quarters · filed 2024-11-14 | 171.88M shares 10-Q · filed 2024-11-14 | 171.40M shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 170.59M shares 10-Q · filed 2024-08-08 | 170.36M shares 10-Q · filed 2024-08-08 | 170.24M shares derived: average of 3 quarters · filed 2024-08-08 | 170.13M shares derived: average of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | 170.13M shares 10-Q · filed 2024-05-09 | 170.06M shares derived: average of 2 quarters · filed 2024-05-09 | 169.97M shares derived: average of 3 quarters · filed 2024-05-09 | 169.91M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 170.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 169.89M shares derived: average of 2 quarters · filed 2024-03-07 | 169.84M shares derived: average of 3 quarters · filed 2024-03-07 | 169.79M shares 10-K · filed 2024-03-07 | |||
| 2022-09-30 | 169.79M shares 10-Q · filed 2023-11-09 | 169.76M shares derived: average of 2 quarters · filed 2023-11-09 | 169.72M shares 10-Q · filed 2023-11-09 | 169.45M shares derived: average of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | 169.73M shares 10-Q · filed 2023-08-10 | 169.69M shares 10-Q · filed 2023-08-10 | 169.34M shares derived: average of 3 quarters · filed 2023-08-10 | 168.91M shares derived: average of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | 169.65M shares 10-Q · filed 2023-05-11 | 169.65K shares 10-Q · filed 2022-05-12 | 169.15M shares derived: average of 2 quarters · filed 2023-05-11 | 168.64M shares derived: average of 3 quarters · filed 2023-05-11 | 167.21M shares derived: average of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | 168.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 168.14M shares derived: average of 2 quarters · filed 2023-03-09 | 166.40M shares derived: average of 3 quarters · filed 2023-03-09 | 164.50M shares 10-K · filed 2023-03-09 | |||
| 2021-09-30 | 167.62M shares 10-Q · filed 2022-11-10 | 165.27M shares derived: average of 2 quarters · filed 2022-11-10 | 163.12M shares 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | 162.91M shares 10-Q · filed 2022-08-11 | 162.91K shares 10-Q · filed 2021-08-12 | 160.83M shares 10-Q · filed 2022-08-11 | 160.83K shares 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 158.72K shares 10-Q · filed 2022-05-12 | 158.72M shares 10-Q · filed 2021-05-13 | |||||
| 2020-09-30 | 149.97M shares 10-Q · filed 2021-11-10 | 75.06M shares derived: average of 2 quarters · filed 2021-11-10 | 149.87M shares 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | 149.82K shares 10-Q · filed 2021-08-12 | 149.82M shares 10-Q · filed 2020-08-06 | 149.81K shares 10-Q · filed 2021-08-12 | 149.81M shares 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | 149.81M shares 10-Q · filed 2021-05-13 | ||||||
| 2019-09-30 | 149.66M shares 10-Q · filed 2020-11-04 | 149.62M shares derived: average of 2 quarters · filed 2020-11-04 | 144.10M shares 10-Q · filed 2020-11-04 | ||||
| 2019-06-30 | 149.58M shares 10-Q · filed 2020-08-06 | 141.27M shares 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | 132.87M shares 10-Q · filed 2020-05-07 | ||||||
| 2018-09-30 | 126.88M shares 10-Q · filed 2019-11-12 | 126.88M shares derived: average of 2 quarters · filed 2019-11-12 | 126.87M shares 10-Q · filed 2019-11-12 | 126.39M shares derived: average of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | 126.87M shares 10-Q · filed 2019-08-08 | 126.87M shares 10-Q · filed 2019-08-08 | 126.23M shares derived: average of 3 quarters · filed 2019-08-08 | 123.49M shares derived: average of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | 126.87M shares 10-Q · filed 2019-05-09 | 126.87K shares 10-Q · filed 2018-05-10 | 125.90M shares derived: average of 2 quarters · filed 2019-05-09 | 122.36M shares derived: average of 3 quarters · filed 2019-05-09 | 119.49M shares derived: average of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | 124.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 120.11M shares derived: average of 2 quarters · filed 2018-11-08 | 117.03M shares derived: average of 3 quarters · filed 2018-11-08 | 114.48M shares 10-K · filed 2018-03-15 | |||
| 2017-09-30 | 115.29M shares 10-Q · filed 2018-11-08 | 115.29K shares 10-Q · filed 2017-11-09 | 113.08M shares derived: average of 2 quarters · filed 2018-11-08 | 110.99M shares 10-Q · filed 2018-11-08 | 110.99K shares 10-Q · filed 2017-11-09 | 153.81M shares derived: average of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | 110.87M shares 10-Q · filed 2018-08-02 | 110.87K shares 10-Q · filed 2017-08-09 | 108.80M shares 10-Q · filed 2018-08-02 | 108.80K shares 10-Q · filed 2017-08-09 | 166.65M shares derived: average of 3 quarters · filed 2018-08-02 | 125.02M shares derived: average of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | 106.71K shares 10-Q · filed 2018-05-10 | 194.54M shares derived: average of 2 quarters · filed 2018-05-10 | 129.73M shares derived: average of 3 quarters · filed 2018-05-10 | 97.32M shares derived: average of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | 388.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 194.54M shares derived: average of 2 quarters · filed 2018-03-15 | 129.72M shares derived: average of 3 quarters · filed 2018-03-15 | 97.32M shares 10-K · filed 2018-03-15 | |||
| 2016-09-30 | 102.71K shares 10-Q · filed 2017-11-09 | 97.98K shares derived: average of 2 quarters · filed 2017-11-09 | 95.48K shares 10-Q · filed 2017-11-09 | 79.72M shares derived: average of 4 quarters · filed 2018-03-15 | |||
| 2016-06-30 | 93.24K shares 10-Q · filed 2017-08-09 | 91.83K shares 10-Q · filed 2017-08-09 | 106.26M shares derived: average of 3 quarters · filed 2018-03-15 | 79.72M shares derived: average of 4 quarters · filed 2018-03-15 | |||
| 2016-03-31 | 90.42K shares 10-Q · filed 2017-05-10 | 159.35M shares derived: average of 2 quarters · filed 2018-03-15 | 106.26M shares derived: average of 3 quarters · filed 2018-03-15 | 79.71M shares derived: average of 4 quarters · filed 2018-03-15 | |||
| 2015-12-31 | 318.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 159.34M shares derived: average of 2 quarters · filed 2018-03-15 | 106.26M shares derived: average of 3 quarters · filed 2018-03-15 | 79.71M shares 10-K · filed 2018-03-15 | |||
| 2015-09-30 | 79.22K shares 10-Q · filed 2016-11-04 | 78.79K shares derived: average of 2 quarters · filed 2016-11-04 | 78.62K shares 10-Q · filed 2016-11-04 | ||||
| 2015-06-30 | 78.36K shares 10-Q · filed 2016-08-09 | 78.31K shares 10-Q · filed 2016-08-09 | |||||
| 2014-12-31 | 66.47M shares 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |